Recruiting

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

Brazil

Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul

Hospital das Clínicas Botucatu, Botucatu

Hospital das Clínicas - UNICAMP, Campinas

Hospital Universitário Maria Aparecida Pedrossian, Campo Grande

Hospital das Clínicas UFPR, Curitiba

Hospital Geral de Fortaleza, Fortaleza

Clinica Neurologica e Neurocirurgica de Joinville, Joinville

Hospital Metropolitano de Maceió, Maceió

Hospital de Clínicas de Porto Alegre, Porto Alegre

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo, Ribeirão Preto

Hospital de Base São José do Rio Preto, São José do Rio Preto

Hospital São Paulo, São Paulo

Santa Casa de Misericordia de Sao Paulo, São Paulo

Hospital Estadual Central, Vitória